Egilius L.H. Spierings

Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study

David W. Dodick, Peter J. Goadsby, Egilius L.H. Spierings et al. · The Lancet Neurology · 2014 · 365 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Precipitating and Aggravating Factors of Migraine Versus Tension‐type Headache

Egilius L.H. Spierings, Anniek H. Ranke, Peter C. Honkoop · Headache The Journal of Head and Face Pain · 2001 · 356 citations

Life Sciences, Neurology, Health Psychology +11

tDCS‐Induced Analgesia and Electrical Fields in Pain‐Related Neural Networks in Chronic Migraine

Alexandre F. DaSilva, Mariana E. Mendonça, Soroush Zaghi et al. · Headache The Journal of Head and Face Pain · 2012 · 306 citations · Full text

Life Sciences, Neurology, Neuroscience +17

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56‐Week PREEMPT Clinical Program

Sheena K. Aurora, Paul Winner, Marshall C. Freeman et al. · Headache The Journal of Head and Face Pain · 2011 · 300 citations

Medicine, Pharmacology, Pharmacotherapy +17

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

Marcelo E. Bigal, Lars Edvinsson, Alan M. Rapoport et al. · The Lancet Neurology · 2015 · 260 citations

Medicine, Neurology, Preventive Medicine +9